This study uses HyGieaCare and biological microbiome therapy in an attempt to provide relief for people with chronic constipation. This platform and form of therapy is administered to help researchers better understand the gut microbiome.
The microbiome and HyGieaCare therapies will be given to subjects with constipation and without constipation. This is to determine if the therapies are effective or just serve as a placebo, with no medicinal benefit.
- All sexes, ages 18 to 80 years old.
- For the healthy population – Indication for age-appropriate colorectal cancer screening colonoscopy
- Able to provide to consent to study
- For the “chronic constipation” population – Patient does not have any known health issues, except for chronic constipation
- Have not taken antibiotics within the last three (3) months.
- For chronically constipated patients – More than 3 months of symptomatic constipation with first occurrence over 6 months ago.
- Functional bowel disorders characterized by alternating bowel habits (diarrhea/constipation)
- Any condition that, in the opinion of the investigator, may negatively affect the compliance or safety of the patient or would limit the patient’s ability to complete the study
- Current, or recent (within three months) antibiotic usage
- Congestive heart failure (NYHA class III or IV or EF <50%)
- Intestinal perforation
- Carcinoma of the rectum
- Fissures or fistula
- Severe hemorrhoids
- Abdominal hernia
- Recent colon or rectal surgery
- Abdominal surgery
- Renal insufficiency (CC < 60 ml/min/173m2)
- Cirrhosis with ascites
- Abdominal surgery within the last 6 months
You may participate in this study at HyGieaCare Center in Norfolk, Virgina, 23502. If you any questions feel free to contact April Fenner, RN at 214-509-6855 or at firstname.lastname@example.org.
This study is sponsored by HyGieaCare, Inc. with David A. Johnson, MD as the Principal Investigator.
Clinical TrialsView All Clinical Trials
Efficacy and Safety of SYN-010 in IBS-C
Cedars-Sinai Medical Center is holding a clinical trial on the effectiveness of SYN-010 in the treatment of…
Linaclotide Safety and Efficacy in 2 to 5-Year-Olds
Allergen and Ironwood Pharmaceuticals Inc. are holding a clinical trial on the effectiveness of the drug…
Efficacy of Psychological Therapies in Patients With Functional Bowel Disorders
Indiana University is holding a clinical trial that analyzes the numerous factors that may contribute to functional…
Low FODMAP Plus PEG 3350 for the Treatment of Patients With Irritable Bowel Syndrome-Constipation
The University of Michigan is testing the effectiveness of PEG 3350 (Miralax) and low FODMAP diet for people with…
Transcutaneous Electrical Acupoint Stimulation for Chronic Constipation
The University of California, Los Angeles, is studying transcutaneous…